SRDX - Surmodics, Inc.
NEXT EARNINGS:
Apr 28, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
614.51M
Volume:
5,342,690
Avg Volume:
435,959
52 Week Range:
25.87-43.0048
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.39
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
389
IPO Date:
1998-03-04
EPS (TTM):
-0.82
P/E Ratio:
-47.55
Revenue (TTM):
126.08M
Total Assets:
178.56M
Total Debt:
33.24M
Cash & Equiv:
36.12M
Rev Growth (5Y):
4.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-2.5%
Debt/Equity:
0.28
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-08-08 | $0.06 | $-0.21 | +128.6% | $29.6M | $30.0M | -1.4% |
| 2025-04-30 | $-0.13 | $-0.06 | -116.7% | $28.1M | $32.2M | -12.9% |
| 2025-01-30 | $-0.04 | $-0.12 | +66.7% | $29.9M | $33.4M | -10.3% |
| 2024-11-06 | $-0.13 | $-0.27 | +51.9% | $33.2M | $30.4M | +9.3% |
| 2024-07-31 | $-0.27 | $-0.31 | +12.9% | $30.3M | $30.4M | -0.2% |
| 2024-05-01 | $0.07 | $-0.36 | +119.4% | $32.0M | $28.8M | +10.8% |
| 2024-02-01 | $-0.06 | $-0.30 | +81.4% | $30.6M | $29.6M | +3.1% |
| 2023-11-08 | $0.53 | $0.19 | +178.9% | $28.0M | $26.3M | +6.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 126.08M | 132.58M | 99.95M | 105.14M | 94.86M | 100.08M | 81.34M | 73.11M | 71.37M | 61.90M | 57.44M | 56.13M |
| Net Income | (11.54M) | (1.54M) | (27.27M) | 4.24M | 1.12M | 7.59M | (4.46M) | 3.93M | 9.98M | 13.45M | 12.03M | 15.17M |
| EPS | -0.82 | -0.11 | -1.96 | 0.31 | 0.08 | 0.57 | -0.34 | 0.30 | 0.77 | 1.03 | 0.88 | 1.05 |
| Total Assets | 178.56M | 185.73M | 158.36M | 194.59M | 168.76M | 159.87M | 164.13M | 136.59M | 132.89M | 100.21M | 104.89M | 101.92M |
| Total Debt | 33.24M | 33.25M | 14.81M | 13.71M | 3.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 36.12M | 41.42M | 19.00M | 31.15M | 30.79M | 30.36M | 23.32M | 16.53M | 24.99M | 55.59M | 43.51M | 15.49M |
| Operating Cash Flow | 248,000 | 10.51M | (17.22M) | 15.39M | 14.01M | 8.04M | 34.05M | 14.05M | 25.17M | 15.02M | 18.18M | 17.66M |
| Free Cash Flow | (3.24M) | 7.60M | (20.59M) | 9.11M | 10.34M | 1.29M | 19.96M | 7.62M | 16.97M | 13.14M | 15.91M | 15.75M |
| FCF per Share | -0.23 | 0.54 | -1.48 | 0.66 | 0.76 | 0.10 | 1.52 | 0.58 | 1.31 | 1.01 | 1.17 | 1.09 |
| Book Value | 118.90M | 119.91M | 108.39M | 140.09M | 131.06M | 122.52M | 108.61M | 111.56M | 106.83M | 93.37M | 98.75M | 93.82M |
| Cash & ST Investments | 40.11M | 45.35M | 19.00M | 38.87M | 61.10M | 55.29M | 64.67M | 48.34M | 46.94M | 55.59M | 46.55M | 25.71M |
| ROC Equity | -0.10 | -0.01 | -0.25 | 0.03 | 0.01 | 0.06 | -0.04 | 0.04 | 0.09 | 0.14 | 0.12 | 0.16 |